A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group.

@article{Boguniewicz1998ARV,
  title={A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group.},
  author={Mark Boguniewicz and Virginia C Fiedler and Sharon A S Raimer and I D Lawrence and Donald Y. M. Leung and Jon M. Hanifin},
  journal={The Journal of allergy and clinical immunology},
  year={1998},
  volume={102 4 Pt 1},
  pages={637-44}
}
BACKGROUND A topical formulation of tacrolimus, an immunosuppressant currently marketed for the prevention of rejection after solid organ transplant, is a potential therapeutic agent for atopic dermatitis. OBJECTIVE We sought to determine the safety and efficacy of tacrolimus ointment in pediatric patients with moderate-to-severe atopic dermatitis… CONTINUE READING